Forte Biosciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Forte biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Forte Biosciences Today - Breaking & Trending Today

Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Update

Forte Biosciences, Inc. (NASDAQ:FBRX – Get Free Report) saw a significant decrease in short interest in May. As of May 15th, there was short interest totalling 25,100 shares, a decrease of 12.8% from the April 30th total of 28,800 shares. Based on an average daily trading volume, of 25,800 shares, the days-to-cover ratio is currently […] ....

United States , Forte Biosciences , Forte Biosciences Company Profile , Forte Biosciences Inc , Cable Car Capital , Securities Exchange Commission , Get Free Report , Car Capital , Free Report , Capital Management , Forte Biosciences Daily ,

Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Down 12.8% in May

Forte Biosciences, Inc. (NASDAQ:FBRX – Get Free Report) saw a large drop in short interest in May. As of May 15th, there was short interest totalling 25,100 shares, a drop of 12.8% from the April 30th total of 28,800 shares. Based on an average daily volume of 25,800 shares, the short-interest ratio is currently 1.0 […] ....

United States , Forte Biosciences , Cable Car Capital , Forte Biosciences Inc , Forte Biosciences Company Profile , Securities Exchange Commission , Get Free Report , Biosciences Stock Down , Capital Management , Car Capital , Free Report , Forte Biosciences Daily ,

Brookline Capital Management Initiates Coverage on Forte Biosciences (NASDAQ:FBRX)

Equities researchers at Brookline Capital Management assumed coverage on shares of Forte Biosciences (NASDAQ:FBRX – Get Free Report) in a report issued on Thursday, Benzinga reports. The firm set a “buy” rating and a $4.00 price target on the stock. Brookline Capital Management also issued estimates for Forte Biosciences’ Q2 2024 earnings at ($0.16) EPS, […] ....

United States , Forte Biosciences , Forte Bioscience , Forte Biosciences Inc , Fred Alger Management , Exchange Commission , Forte Biosciences Company Profile , Brookline Capital Management , Get Free Report , Capital Management , Biosciences Stock Down , Alger Management , Free Report , Forte Biosciences Daily ,

Forte Biosciences (NASDAQ:FBRX) Now Covered by Brookline Capital Management

Stock analysts at Brookline Capital Management initiated coverage on shares of Forte Biosciences (NASDAQ:FBRX – Get Free Report) in a note issued to investors on Thursday, Benzinga reports. The brokerage set a “buy” rating and a $4.00 price target on the stock. Brookline Capital Management also issued estimates for Forte Biosciences’ Q2 2024 earnings at […] ....

United States , Forte Bioscience , Forte Biosciences , Forte Biosciences Inc , Exchange Commission , Forte Biosciences Company Profile , Cable Car Capital , Brookline Capital Management , Get Free Report , Capital Management , Car Capital , Free Report , Forte Biosciences Daily ,

Traders Purchase Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX)

Forte Biosciences, Inc. (NASDAQ:FBRX – Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock traders acquired 30,205 call options on the company. This represents an increase of 1,663% compared to the typical volume of 1,713 call options. Forte Biosciences Trading Up 2.5 % Shares of FBRX stock opened at […] ....

United States , Forte Biosciences , Securities Exchange Commission , Forte Biosciences Inc , Fred Alger Management , Get Free Report , Alger Management , Free Report , Capital Management , Forte Biosciences Daily ,